NCT01401504View on ClinicalTrials.gov

Study of an Investigational Drug, ASP3026, in Patients With Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Solid Tumor
Interventions
DRUG

ASP3026

oral

Trial Locations (1)

Unknown

Kansai

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY